Margaret Shipp, HMS professor of medicine at Dana-Farber, has been elected to the 2022 class of Fellows of the American Association for Cancer Research. The fellowship recognizes researchers whose scientific contributions have propelled innovation and progress against cancer.
Shipp was recognized for her clinical cancer research studies of the genetic and molecular basis and heterogeneity of large B-cell lymphomas and Hodgkin lymphomas, the identification of molecular signatures of molecular signatures of biologically distinct subsets of these diseases, and the development of the International Prognostic Index.
Andreas Horn, HMS member of the faculty of neurology at Brigham and Women’s, has been named to receive the Heinz Maier-Leibnitz Prize from the German Research Foundation. The award recognizes early career investigators in Germany.
Horn was recognized for his work with imaging methods to study brain function, with a focus on understanding and modulating neuronal networks in the brain. Horn’s work enables symptomatic treatment of patients with movement disorders such as Parkinson’s disease, epilepsies, and obsessive-compulsive disorders.
Joseph Arboleda-Velasquez, HMS assistant professor of ophthalmology at Schepens, was awarded a 2022 Edward N. & Della L. Thome Memorial Foundation Award. The Thome Memorial Foundation Awards Program in Alzheimer’s Disease Drug Discovery Research supports innovative drug discovery research that will lead to improved therapies for individuals living with Alzheimer’s disease.
Arboleda-Velasquez was recognized for his research involving antibodies that mimic the effect of a rare genetic variation linked to Alzheimer’s protection—called APOE3 Christchurch—with the goal of developing drug and gene therapies for Alzheimer’s.
Nazlee Zebardast, HMS assistant professor of ophthalmology at Mass Eye and Ear, was awarded a Research to Prevent Blindness 2021 Career Development Award. The award supports promising junior ophthalmology faculty who have demonstrated their potential for independent research.
The award will support Zebardast’s research to develop novel imaging and genomics-based screening and diagnostic tools for glaucoma. She hopes these tools will not only pre-symptomatically identify glaucoma patients at high risk of functional vision loss and progression, but also help avoid unnecessary care for those whose conditions are unlikely to worsen.
